LTIMindtree shares rose 3.6% to Rs 5,950 after Kotak Institutional Equities upgraded the stock and raised its target price to Rs 6,200, citing recovery prospects and strong growth. The company also received a stay order on a Rs 378 crore GST notice.
Reseñas
Canada’s planned cap on low wage foreign workforce a temporary pause; they need people to grow their GDP: Santosh Rao
Santosh Rao of Manhattan Venture Partners discusses the demand for skilled and unskilled workers in the US and Canada. He highlights the strain on local infrastructure and educational systems due to immigration. Rao emphasizes the need for balanced immigration policies amidst economic challenges and an undercurrent of xenophobia in some Continue Reading
This Ashish Kacholia portfolio stock rallies over 1,000% in 2 years. Should you ride the rally?
Shares of Balu Forge Industries, backed by investor Ashish Kacholia, have surged over 1300% in the last two years, driven by strong profit growth. The stock, which manufactures crankshafts and forged components, saw profit booking on Monday, falling by 1.5%. Experts suggest monitoring the Rs 740 and Rs 800 levels Continue Reading
Stocks to buy today: REC, Castrol India among top 6 trading ideas for August 28, 2024
The Indian market is expected to consolidate on Wednesday with mixed global cues. Nifty futures fell 0.17% to 25,001. India VIX decreased to 13.70. Options data suggests a broader range of 24,600-25,500 and an immediate range of 24,800-25,300. Key support is at 24,900 and 24,800.
Fund Manager Talk | Zomato’s turnaround inspiring confidence in other new-age stocks: Arvind Kothari
This strategy allows us to remain invested and benefit from the long-term growth potential while being cautious and adaptive to the changing market dynamics.
‘Defensive’ pharma scales new peak as Street looks beyond high-growth plays
Pharma stocks have gained investor interest as the Nifty Pharma index reaches new highs. Amid economic uncertainties, defensive sectors like pharma offer minimal risk. Notable picks include Lupin, Sun Pharma, and Dr Reddy’s. The sector saw significant foreign inflows, driven by the performance of the generic drug Revlimid.
Adani Enterprises likely to launch Rs 800-crore public bond issue on Sept 4
Adani Enterprises plans to launch a public bond issue worth ₹800 crore on September 4. The issue, managed by the Trust Group, AK Capital, and Nuvama Wealth Management, has a base size of ₹400 crore and an option to keep another ₹400 crore under the green shoe option. The bonds Continue Reading
NSE plans to refile for NOC to proceed with Rs 30,000-cr IPO
The National Stock Exchange is set to refile for an initial public offering with the Securities and Exchange Board of India after addressing regulatory issues. The IPO, expected to be India’s largest, is anticipated to raise ₹30,000 crore. NSE aims to secure the no-objection certificate needed to proceed with its Continue Reading
SME IPOs spark a gold rush as investors eye big bounties
The Indian primary market has seen a surge in interest for SME IPOs, with massive oversubscriptions. Data from Prime Database reveals that 152 SME IPOs this year averaged 200 times oversubscribed. While SEBI urges caution, the lure of robust listing gains and stock performance continues to draw investors.
Asian stocks cautious as markets await Nvidia: Markets wrap
Asian stocks dipped as traders await Nvidia’s earnings to gauge the AI market’s strength. With Japan and Australia’s markets seeing declines and Nvidia accounting for over 6% of S&P 500’s market cap, all eyes are on the giant chipmaker. Recent US consumer confidence data highlighted mixed economic sentiment.